NorthWest Biotherapeutics Inc (NWBO)

[iwasadiver]

I actually agree with you that it’s a valuation issue. But that alone goes back to my idea of large corporate hubris and refusal to think anything’s as good as what they came up with and found on there own. They try to buy out early but in NWBO’s case who knows what happened. The hold, the following short selling, etc. But the overall technology, in my opinion as someone who’s dug deep, is that DCVax is bigger than anything that’s come along because it’s a broader sword even if individualized because it’s not so finely targeted to a single defined target molecule. I see DCVax as the base treatment by which any and all others will be secondary to. That makes it a formidable technology to ignore and yet one Linda Powers is not going to give away even remotely.